Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
posted on
Oct 15, 2024 01:09PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Yes , hope sure runs low with the boasting , over promising underperforming blowhard.
maybe the agm is being delayed as they sort out a deal of sorts. Last rumour heard was NOT to expect ANY dividend/money of any kind being funnelled back to shareholders.
The only positive is , any rumours that have ever been spread have never come true.
He's living in a fantasy world dreaming about his little pharma company.Problem is he's getting paid for his BS dreams.Its like a cult , everyone around him lives , dreams & promotes this BS.